Human epidermal growth factor receptor 2 (HER2) protein overexpression is present in approximately 20% of breast cancer cases, resulting in a more aggressive natural subtype of the disease, poor prognosis [4], higher relapse, and higher mortality rates [5]. The gene discussed is ERBB2; the disease is breast carcinoma.